BRIEF published on 06/10/2024 at 14:05, 5 months 11 days ago CCL Industries Completes Acquisition of 100% of Middle East Venture Acquisition Middle East CCL Industries Pacman-CCL Albwardy Investment
PRESS RELEASE published on 06/10/2024 at 14:00, 5 months 11 days ago CCL Industries Completes Acquisition of 100% of Middle East Venture CCL Industries Inc. completes acquisition of remaining equity interest in Middle East joint venture, Pacman-CCL. Business will trade as CCL Label with consolidated results Acquisition Middle East CCL Industries Inc. Pacman-CCL CCL Label
BRIEF published on 05/23/2024 at 14:05, 5 months 29 days ago CCL Industries Inc. Announces TSX Acceptance of Normal Course Issuer Bid TSX Stock Buyback Class B Shares CCL Industries Issuer Bid
PRESS RELEASE published on 05/23/2024 at 14:00, 5 months 29 days ago CCL Industries Inc. Announces TSX Acceptance of Normal Course Issuer Bid CCL Industries Inc. announces normal course issuer bid to acquire up to 9.93% of its Class B non-voting shares on the TSX from May 25, 2024, to May 24, 2025 Normal Course Issuer Bid Stock Exchange TSX CCL Industries Inc. Class B Non-voting Shares
BRIEF published on 05/13/2024 at 14:05, 6 months 8 days ago CCL Industries Expands Ownership in Middle East Venture Acquisition Middle East CCL Industries Inc. Pacman-CCL Equity Interest
PRESS RELEASE published on 05/13/2024 at 14:00, 6 months 8 days ago CCL Industries Signs Agreement to Acquire 100% of Middle East Venture CCL Industries Inc. acquires remaining 50% equity in Middle East joint venture, Pacman-CCL, from Albwardy Investment LLC. Transaction pending regulatory approvals Acquisition Middle East Joint Venture CCL Industries Inc. Pacman-CCL
BRIEF published on 05/10/2024 at 23:05, 6 months 10 days ago CCL Industries Inc. Announces Key Results from 2024 Annual Shareholders' Meeting Corporate Governance Shareholders' Meeting Director Elections CCL Industries Vote Results
PRESS RELEASE published on 05/10/2024 at 23:00, 6 months 10 days ago CCL Industries Announces 2024 Annual and Special Shareholders’ Meeting Results CCL Industries Inc. announces successful voting results from 2024 Annual and Special Meeting of Shareholders, including approval of director elections and amendment to Deferred Share Unit Plan Voting Results Annual And Special Meeting CCL Industries Inc. Director Elections Deferred Share Unit Plan
BRIEF published on 05/09/2024 at 23:05, 6 months 11 days ago CCL Industries Announces Plans to Renew Share Buyback Program Share Repurchase TSX Stock Buyback CCL Industries NCIB
BRIEF published on 05/08/2024 at 23:35, 6 months 12 days ago CCL Industries Reports Record First Quarter Results for 2024 Global Expansion Financial Results Record Earnings Quarterly Growth CCL Industries Inc
Published on 11/21/2024 at 14:15, 17 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 32 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 32 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 32 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 15 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 17 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 56 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 34 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 12 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
